此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

患有唐氏综合症和阻塞性睡眠呼吸暂停的儿童和青少年的氧疗 (DOSA)

2026年9月25日 更新者:Susan Redline、Brigham and Women's Hospital

唐氏综合症和阻塞性睡眠呼吸暂停儿童和青少年氧疗的随机对照试验

The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) with moderate to severe Obstructive Sleep Apnea (OSA).

研究概览

地位

招聘中

干预/治疗

详细说明

This will be a randomized, single-blind 6-month Phase-2 clinical trial that compares the impact of oxygen therapy during sleep on measures of cognition, behavior, quality of life, cardiac structure and function, and sleep in children with Down Syndrome(DS) with moderate to severe obstructive sleep apnea.

The proposed study will involve participation of children and their caregivers. Children will be recruited from each site's sleep clinics and laboratories, Down syndrome clinics and otolaryngology clinics. Community recruitment will be coordinated with local Down Syndrome Associations.

Children who agree to participate in the study will be screened for eligibility based on history, physical examination, and review of medical records including history of congenital heart disease and Pulmonary Hypertension (PHTN), and use of Continuous Positive Airway Pressure (CPAP). Children eligible for the study are those with persistent obstructive apnea after adenotonsillectomy or children with obstructive sleep apnea without adenotonsillar hypertrophy or in situations when parents refuse adenotonsillectomy.. The enrollment PSG eligibility will be determined by central scoring of either a research Polysomnography (PSG). In addition to an oxygen titration PSG, which determines responsiveness to oxygen, participants will be asked to wear a wrist actigraph and undergo neurocognitive testing, echocardiography, physical examination, anthropometry, and venipuncture. Caregivers will complete questionnaires to assess their child's emotional, physical, social, and school functioning, sleep quality; child's behavior and cognitive function, and will complete a sleep diary that is used concurrently with their child's use of a wrist actigraph. The latter includes caregiver completion of the "Behavior Rating Inventory of Executive Function" (BRIEF2), a co-primary outcome.

At 3 months, caregivers will complete the BRIEF2. At 6 months, all baseline studies and a PSG will be repeated.

At baseline, demographic data will be collected, including information on residential address (for use in geocoding).

研究类型

介入性

注册 (估计的)

230

阶段

  • 阶段2

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • California
      • Los Angeles、California、美国、90027
        • 招聘中
        • Children's Hospital of Los Angeles
        • 接触:
        • 首席研究员:
          • Sally Ward, MD
    • Michigan
      • Ann Arbor、Michigan、美国、48109
        • 招聘中
        • University of Michigan, Ann Arbor Hospital
        • 接触:
        • 首席研究员:
          • Ronald Chervin, MD
    • Ohio
      • Cincinnati、Ohio、美国、45229
        • 招聘中
        • Cincinnati Children's Hospital Medical Center
        • 首席研究员:
          • Raouf Amin, MD
        • 接触:
      • Cleveland、Ohio、美国、44106
        • 招聘中
        • Rainbow Babies and Children's Hospital, Case Medical Center
        • 接触:
        • 首席研究员:
          • Sally Ibrahim, MD
    • Pennsylvania
      • Philadelphia、Pennsylvania、美国、19104
        • 招聘中
        • Children's Hospital of Philadelphia
        • 接触:
        • 首席研究员:
          • Christopher Cielo, MD
    • Virginia
      • Norfolk、Virginia、美国、23507
        • 招聘中
        • East Virginia Medical Center
        • 接触:
        • 首席研究员:
          • Cristina Baldassari, MD
    • Washington
      • Seattle、Washington、美国、98105

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

5年 至 18年 (孩子、成人)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Ages 5.0 to 17.9 years at the time of screening

  2. Children with OSA and obstructive apnea hypopnea index (OAHI) ≥5/hour.

  3. Absence of clinically significant hypoxia defined as oxygen saturation <88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen.

  4. Favorable response to oxygen therapy (allowing randomization) will be defined as follows:

    1. Oxygen saturation nadir >92% and
    2. Decrease in obstructive index < 5 / hour or by > 50% from screening PSG
    3. Reaching an optimum oxygen flow which is defined as the flow that achieves the lowest level of AHI with maximum CO2 level less than 65 mmHg observed for 5 consecutive minutes and or an increase in CO2 by less than 15 points above baseline. The above criteria are observed while the patient spends a minimal of 30 minutes in the supine position and at least one cycle of rapid eye movement (REM) sleep.
    4. Oxygen flow required does not exceed 3.0 LPM and does not exceed a FiO2 > 40 %.
  5. Willingness to comply with all study procedures and available for duration of study.

  6. At baseline the participant attempts to perform the neuropsychological tests

Exclusion Criteria:

  1. Current CPAP use with documented compliance(> 4 hrs/ night; > 70% of nights).
  2. Oxygen saturation < 90% at rest during wakefulness.
  3. Chronic daytime or nighttime use of supplemental oxygen.
  4. Smoker in the child's bedroom.
  5. Unrepaired congenital heart disease.
  6. Moderate to severe pulmonary hypertension requiring treatment with oxygen and or pulmonary vasodilator.
  7. Unable to participate in a PSG.
  8. Individuals who develop alveolar hypoventilation with oxygen as previously defined.
  9. Other severe chronic diseases determined by their provider as making them poor study candidates.
  10. Enrolled or planning to enroll in another study that may conflict with protocol requirements or confound results in this trial.
  11. Documented clinically significant untreated hypothyroidism
  12. Children with adenotonsillar hypertrophy who are candidates for adenotonsillectomy and parents agree to the surgery.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
有源比较器:Oxygen plus supportive care (OXT)

Nocturnal oxygen therapy plus providing patient with healthy sleep habits materials, healthy diet materials and nasal dilators.

Active nocturnal oxygen concentrator

无干预:Supportive care (SC)

Providing patient with healthy sleep habits materials, healthy diet materials and nasal dilators.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Behavior Rating Inventory of Executive Function 2 (BRIEF2) working memory score
大体时间:Baseline and 6 months

Change from baseline in the Behavior Rating Inventory of Executive Function 2 (BRIEF2) working memory score (BRIEF2wm). The score ranges from 35-90. A higher score is a worse outcome.

Baseline and 6 months
Differential Ability Scales - 2nd Edition (DAS-II) T-score.
大体时间:Baseline and 6 months

Change from baseline in the Differential Ability Scales - 2nd Edition (DAS-II) recognition of pictures (DAS2RoP) T-score. The score ranges from 10-90. A higher score is a better outcome.

Baseline and 6 months

次要结果测量

结果测量
措施说明
大体时间
Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Total raw score
大体时间:Baseline and 6 Months

Change from baseline of Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Total raw score. The score ranges from 0-64. A higher score is a better outcome.

Baseline and 6 Months
Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Verbal raw score
大体时间:Baseline and 6 Months

Change from baseline of Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Verbal raw score. The score ranges from 0-30. A higher score is a better outcome.

Baseline and 6 Months
Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Non Verbal raw score
大体时间:Baseline and 6 Months

Change from baseline of Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Non Verbal raw score. The score ranges from 0-34. A higher score is a better outcome.

Baseline and 6 Months
Differential Ability Scales-2 (DAS-II) Recall of Digits Forward raw score
大体时间:Baseline and 6 Months

Change from baseline in Differential Ability Scales-2 (DAS-II) Recall of Digits Forward raw score. The score ranges from 0-38. A higher score is a better outcome.

Baseline and 6 Months
Cambridge Neuropsychological Test Automated Battery (CANTAB) Paired Associates Learning (PAL) adjusted total errors based on stages completed
大体时间:Baseline and 6 Months

Change from baseline in Cambridge Neuropsychological Test Automated Battery (CANTAB) Paired Associates Learning (PAL) adjusted total errors based on stages completed

Baseline and 6 Months
Cambridge Neuropsychological Test Automated Battery (CANTAB) Reaction Time (RTI)
大体时间:Baseline and 6 Months

Change from baseline in Cambridge Neuropsychological Test Automated Battery (CANTAB) Reaction Time (RTI)

Baseline and 6 Months
Developmental Neuropsychological Assessment 2nd Edition (NEPSY-II) verbal fluency test raw score
大体时间:Baseline and 6 Months

Change from baseline in Developmental Neuropsychological Assessment 2nd Edition (NEPSY-II) verbal fluency test raw score. Range-N/A

Baseline and 6 Months
Observer Memory Questionnaire - Parent Form (OMQ-PF) total T-score
大体时间:Baseline and 6 Months

Change from baseline in Observer Memory Questionnaire - Parent Form (OMQ-PF) total T-score. The score ranges from 0-135. A higher score is a better outcome.

Baseline and 6 Months
Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for subscales (Inhibit, Self-Monitor, Shift, Emotional Control, Initiate)
大体时间:Baseline and 6 Months

Change from baseline in Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for subscales (Inhibit, Self-Monitor, Shift, Emotional Control, Initiate).

Baseline and 6 Months
Child Behavior Checklist (CBCL) T-scores for domains (Internalizing, Externalizing, Total Problems).
大体时间:Baseline and 6 Months

Change from baseline in Child Behavior Checklist (CBCL) T-scores for domains (Internalizing, Externalizing, Total Problems).

Baseline and 6 Months
Child Behavior Checklist (CBCL) T-scores for subscales (Attention Problems, Thought Problems, Rule-Breaking Behaviors, Aggressive Behaviors)
大体时间:Baseline and 6 Months

Change from baseline in Child Behavior Checklist (CBCL) T-scores for subscales (Attention Problems, Thought Problems, Rule-Breaking Behaviors, Aggressive Behaviors)

Baseline and 6 Months
KIDSCREEN-27 T-score
大体时间:Baseline and 6 Months

Change from baseline in KIDSCREEN-27 T-score, including domains of: physical well-being; psychological well-being; autonomy and parent relations; social support and peers; school environment. Range-N/A

Baseline and 6 Months
Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance T-score
大体时间:Baseline and 6 Months

Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance T-score. The score ranges from 28.7-85.6. A higher score is a worse outcome.

Baseline and 6 Months
Patient-Reported Outcomes Measurement Information System (PROMIS) sleep-related impairment T-score
大体时间:Baseline and 6 Months

Change from baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) sleep-related impairment T-score. The score ranges from 37.9-86.6. A higher score is a worse outcome.

Baseline and 6 Months
Presence of right ventricular hypertension
大体时间:Baseline and 6 Months

Presence of right ventricular hypertension as measured by tricuspid regurgitation continuous wave peak velocity (defined as a ratio of pulmonary artery pressure / systolic arterial pressure (PAP/SAP) >1/3); interventricular septal flattening as measured by eccentricity index (defined as systolic ratio of >1.25)

Baseline and 6 Months
Wechsler Intelligence Scale (WISC) for Children 5th edition (WISC-5) Cancellation raw score
大体时间:Baseline and 6 Months

Change from baseline of Wechsler Intelligence Scale (WISC) for Children 5th edition (WISC-5) Cancellation raw score. The score ranges from 0-128. A higher score is a better outcome.

Baseline and 6 Months
Wechsler Preschool and Primary Scale of Intelligence 4th edition (WPPSI-4) Cancellation task raw score
大体时间:Baseline and 6 Months

Change from baseline in Wechsler Preschool and Primary Scale of Intelligence 4th edition (WPPSI-4) Cancellation task raw score (if unable to complete Wechsler Intelligence Scale 5th edition Cancellation test). The score ranges from 0-96. A higher score is a better outcome.

Baseline and 6 Months
Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for Behavior Regulation Index (BRI) domain.
大体时间:Baseline and 6 Months

Change from baseline in Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for Behavior Regulation Index (BRI) domain. The score ranges from 35-90. A higher score is a worse outcome.

Baseline and 6 Months
Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for Emotional Recognition Index (ERI) domain.
大体时间:Baseline and 6 Months

Change from baseline in Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for Emotional Recognition Index (ERI) domain. The score ranges from 35-90. A higher score is a worse outcome.

Baseline and 6 Months
Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for Cognitive Regulation Index (CRI) domain.
大体时间:Baseline and 6 Months

Change from baseline in Behavior Rating Inventory of Executive Function 2 (BRIEF2) T-scores for Cognitive Regulation Index (CRI) domain. The score ranges from 35-90. A higher score is a worse outcome.

Baseline and 6 Months
7-day actigraphy measurement of sleep efficiency
大体时间:Baseline and 6 Months

Change from baseline in 7-day actigraphy measurement of sleep efficiency

Baseline and 6 Months
7-day actigraphy measurement of time wake after sleep onset
大体时间:Baseline and 6 Months

Change from baseline in 7-day actigraphy measurement of time wake after sleep onset

Baseline and 6 Months
7-day actigraphy measurement of sleep fragmentation
大体时间:Baseline and 6 Months

Change from baseline in 7-day actigraphy measurement of sleep fragmentation

Baseline and 6 Months
7-day actigraphy measurement of total sleep duration
大体时间:Baseline and 6 Months

Change from baseline in 7-day actigraphy measurement of total sleep duration

Baseline and 6 Months
Polysomnography (PSG) AHI parameter
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) AHI parameter. The score ranges from 0- >40. A higher score is a worse outcome.

Baseline and 6 Months
Polysomnography (PSG) percentage time of O2 <90 % parameter
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) percentage time of O2 <90 % parameter

Baseline and 6 Months
Polysomnography (PSG) sleep apnea associated hypoxic burden parameter
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) sleep apnea associated hypoxic burden, parameter

Baseline and 6 Months
Polysomnography (PSG) end-tidal CO2 level, parameter
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) end-tidal CO2 parameter.

Baseline and 6 Months
Polysomnography (PSG) -based measure of sleep stages
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) -based measure of sleep stages. Range- N/A

Baseline and 6 Months
Polysomnography (PSG) -based measure of EEG power bands
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) -based measure of EEG power bands

Baseline and 6 Months
Polysomnography (PSG) -based measure of spindle morphology
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) -based measure of spindle morphology

Baseline and 6 Months
Polysomnography (PSG) -based measure of spindle numbers
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) -based measure of spindle numbers

Baseline and 6 Months
Polysomnography (PSG) -based measure of spindle density
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) -based measure of spindle density

Baseline and 6 Months
Polysomnography (PSG) -based measure of slow wave oscillations
大体时间:Baseline and 6 Months

Change from baseline in Polysomnography (PSG) -based measure of slow wave oscillations

Baseline and 6 Months
Left ventricular diastolic function as measured by Mitral E and A wave (E:A ratio)
大体时间:Baseline and 6 Months

Change from baseline in left ventricular diastolic function as measured by Mitral E and A wave (E:A ratio)

Baseline and 6 Months
Left ventricular diastolic function as measured by E wave deceleration time
大体时间:Baseline and 6 Months

Change from baseline in left ventricular diastolic function as measured by E wave deceleration time

Baseline and 6 Months
Left ventricular diastolic function as measured by Mitral septal and lateral e' and a' (E/e')
大体时间:Baseline and 6 Months

Change from baseline in left ventricular diastolic function as measured by Mitral septal and lateral e' and a' (E/e')

Baseline and 6 Months
Left ventricular diastolic function as measured by Mitral lateral tissue Doppler isovolumic relaxation time
大体时间:Baseline and 6 Months

Change from baseline in left ventricular diastolic function as measured by Mitral lateral tissue Doppler isovolumic relaxation time

Baseline and 6 Months
Left ventricular diastolic function as measured by Pulmonary vein A wave reversal duration
大体时间:Baseline and 6 Months

Change from baseline in left ventricular diastolic function as measured by Pulmonary vein A wave reversal duration

Baseline and 6 Months
Left ventricular diastolic function as measured by Left atrial volume
大体时间:Baseline and 6 Months

Change from baseline in left ventricular diastolic function as measured by Left atrial volume

Baseline and 6 Months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年10月24日

初级完成 (估计的)

2027年11月30日

研究完成 (估计的)

2027年12月30日

研究注册日期

首次提交

2023年8月17日

首先提交符合 QC 标准的

2023年9月12日

首次发布 (实际的)

2023年9月21日

研究记录更新

最后更新发布 (实际的)

2026年9月30日

上次提交的符合 QC 标准的更新

2026年9月25日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅